Increased matrix metalloproteinase activity after canine cardiopulmonary bypass is suppressed by a nitric oxide scavenger

Journal of Thoracic and Cardiovascular Surgery

Volumn 125, Issue 3, 2003, Pages 661-668

  Mayers, Irvin ^a,e   Hurst, Thomas ^c   Radomski, Anna ^a   Johnson, David ^d   Fricker, Simon ^b   Bridger, Gary ^b   Cameron, Beth ^b   Darkes, Marilyn ^b   Radomski, Marek W ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b GENZYME CORPORATION   (United States)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d UNIVERSITY OF SASKATCHEWAN   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; GELATINASE A; GELATINASE B; LIQUID NITROGEN; MATRIX METALLOPROTEINASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLACEBO;

ANIMAL MODEL; ARTICLE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DOG; ENZYME ACTIVITY; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; INFLAMMATION; LUNG; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

EID: 0037348648     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2003.38     Document Type: Article

References (29)

1. Downing SW, Edmunds LH Jr. Release of vasoactive substances during cardiopulmonary bypass. Ann Thorac Surg. 1992;54:1236-43.
2. Kawamura T, Wakusawa R, Okada K, et al. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of inteleukin 8 and 6 in the reperfusion injury. Can J Anaesth. 1993:40:1016-21.
3. Mayers I, Hurst T, Puttagunta L, et al. Cardiac surgery increases the activity of matrix metalloproteinases and nitric oxide synthase in human hearts. J Throrac Cardiovasc Surg. 2001;122:746-53.
4. Stetler-Stevenson WG, Krutsch HC, Liotta LA. Tissue inhibitor of metalloproteinase (TIMP-2): a new member of the metalloproteinase inhibitor family. J Biol Chem. 1989;264:17374-8.
5. Schulz R, Dodge K, Lopaschuk GD, et al. Peroxynitrite impairs cardiac contractile function by decreasing cardiac efficiency. Am J Physiol. 1997;272:H1212-9.
6. Fricker SP, Slade E, Powell NA, et al. Ruthenium complexes as nitric oxide scavengers: a potential therapeutic approach to nitric oxidemediated diseases. Br J Pharmacol. 1997;122:1441-9.
7. Mayers I, Salas E, Hurst T, et al. Increased nitric oxide synthase activity following canine cardiopulmonary bypass is suppressed by S-nitroso-glutathione. J Thorac Cardiovasc Surg. 1999;117:1009-16.
8. Mayers I, Hurst T, Johnson D, et al. Anti-CD18 antibodies improve cardiac function following cardiopulmonary bypass in dogs. J Crit Care. 1996;11:189-97.
9. Radomski MW, Vallance PJ, Whitely G, et al. Modulation of platelet adhesion to human vascular endothelium by the constitutive and cytokine-inducible nitric oxide synthases. Cardiovasc Res. 1993;27: 1380-2.
10. Sawicki G. Salas E, Murat J, et al. Release of gelatinase A during platelet activation mediates aggregation. Nature. 1997;386:616-8.
11. Mosi R, Seguin B, Cameron B. et al. Mechanistic studies on AMD-6221: a ruthenium-based nitric oxide scavenger. Biochem Biophys Res Commun. 2002;292:519-29.
12. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-12.
13. Breisblatt WM, Stein KL, Wolf CJ, et al. Acute myocardial dysfunction and recovery: a common occurrence after coronary bypass surgery. J Am Coll Cardiol. 1990;15:1261-9.
14. Moro MA, Darley-Usmar V, Goodwin DA, et al. Paradoxical fate and biological action of peroxynitrite on human platelets. Proc Natl Acad Sci U S A. 1994;91:6702-6.
15. Wink DA, Hanbauer I, Krishna MC, et al. Nitric oxide protects again cellular damage and cytotoxicity from reactive oxygen species. Proc Natl Acad Sci U S A. 1993;90:9813-7.
16. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol. 1992;105:575-80.
17. Schulz R, Panas DL, Catena R, et al. The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha. Br J Pharmacol. 1995;14:27-34.
18. Kinugawa KI, Kohmoto O, Yao A, et al. Cardiac inducible nitric oxide synthase negatively modulates myocardial function in cultured rat myocytes. Am J Physiol. 1997;272:H35-47.
19. Lefer DJ, Nakanishi K, Johnson WE et al. Antineutrophil and myocardial protecting actions of a novel nitric oxide donor after myocardial ischemia and reperfusion in dogs. Circulation. 1993;88:2337-50.
20. Matheis G, Sherman MP, Buckberg GD et al. Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol. 1992;262:H616-20.
21. Okamoto T, Akaike T, Nagano T, et al. Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: a novel mechanism for procollagenase activation involving nitric oxide. Arch Biochem Biophys. 1997;342:261-74.
22. Fricker SP. Nitrogen monoxide-related disease and nitrogen monoxide scavengers as potential drugs. In: Sigel A, Sigel H, editors. Metal ions in biological systems. Vol. 36. New York: Marcel Dekker Inc; 1999. p. 665-721.
23. Rouet-Benzineb P, Buhler JM, Dreyfus P, et al. Altered balance between matrix gelatinases (MMP-2 and MMP-9) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP-9 in myosin-heavy chain degradation. Eur J Heart Fail. 1999;1:337-52.
24. Spinale FG, Coker ML, Bond BR, et al. Myocardial matrix degradation and metalloproteinase activation in the failing heart: a potential therapeutic target. Cardiovasc Res. 2000;46:225-38.
25. Morita K, Sherman MP, Buckberg GD, et al. Studies of hypoxemic/ reoxygenation injury: without aortic clamping. V. Role of the Larginine-nitric oxide pathway: the nitric oxide paradox. J Thorac Cardiovasc Surg. 1995;110:1200-11.
26. Segawa D, Hatori N, Yoshizu H, et al. The effect of nitric oxide synthase inhibitor on reperfusion injury of the brain under hypothermic circulatory arrest. Thorac Cardiovasc Surg. 1998;115:925-30.
27. Carney DE, Lutz CJ, Picone AL, et al. Matrix metalloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass. Circulation. 1999;100:400-6.
28. Harris DN, Bailey SM, Smith PLC, et al. Brain swelling in first hour after coronary artery bypass surgery. Lancet. 1993;342:586-7.
29. Roach GW, Kanchuger M, Mangano CM, et al. Adverse cerebral outcomes after coronary bypass surgery. N Engl J Med. 1996;335:1857-63.